| Jennifer Louise Willis, MD | |
|
1300 N 12th St, Suite 605, Phoenix, AZ 85006-2848 | |
| (602) 239-4567 | |
| Not Available |
| Full Name | Jennifer Louise Willis |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 1300 N 12th St, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275731424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 81372 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
| Midwestern University | 6305734773 | 112 |
| Banner Primary Care Physicians Arizona Llc | 6406020155 | 182 |
News Archive
Researchers at the University of Essex, England are embarking on the first phase of a unique project to find out if mobile phone masts, have an adverse effect on our health.
Ajinomoto AminoScience, LLC announced today the launch of AjiPhase™, an evolution of liquid phase peptide synthesis containing the benefits of solid and liquid phase methodologies. This new service is designed as an innovative tool that will enable pharmaceutical companies to expand their development pipeline and provide a uniform production process through the entire development lifecycle.
The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body's internal organs. The AMA's proposals are part of a submission calling for $63 million to fight obesity.
A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.
Chelsea Therapeutics International, Ltd. has completed its previously announced public offering of common stock and announced that the underwriters exercised their option to purchase approximately 1.07 million additional shares to cover over-allotments.
› Verified 7 days ago
| Entity Name | Vhs Outpatient Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912979964 PECOS PAC ID: 4486566726 Enrollment ID: O20031104000523 |
News Archive
Researchers at the University of Essex, England are embarking on the first phase of a unique project to find out if mobile phone masts, have an adverse effect on our health.
Ajinomoto AminoScience, LLC announced today the launch of AjiPhase™, an evolution of liquid phase peptide synthesis containing the benefits of solid and liquid phase methodologies. This new service is designed as an innovative tool that will enable pharmaceutical companies to expand their development pipeline and provide a uniform production process through the entire development lifecycle.
The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body's internal organs. The AMA's proposals are part of a submission calling for $63 million to fight obesity.
A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.
Chelsea Therapeutics International, Ltd. has completed its previously announced public offering of common stock and announced that the underwriters exercised their option to purchase approximately 1.07 million additional shares to cover over-allotments.
› Verified 7 days ago
| Entity Name | Midwestern University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932206414 PECOS PAC ID: 6305734773 Enrollment ID: O20040308000663 |
News Archive
Researchers at the University of Essex, England are embarking on the first phase of a unique project to find out if mobile phone masts, have an adverse effect on our health.
Ajinomoto AminoScience, LLC announced today the launch of AjiPhase™, an evolution of liquid phase peptide synthesis containing the benefits of solid and liquid phase methodologies. This new service is designed as an innovative tool that will enable pharmaceutical companies to expand their development pipeline and provide a uniform production process through the entire development lifecycle.
The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body's internal organs. The AMA's proposals are part of a submission calling for $63 million to fight obesity.
A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.
Chelsea Therapeutics International, Ltd. has completed its previously announced public offering of common stock and announced that the underwriters exercised their option to purchase approximately 1.07 million additional shares to cover over-allotments.
› Verified 7 days ago
| Entity Name | Alliance Urgent Care Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891888517 PECOS PAC ID: 8022111749 Enrollment ID: O20070316000208 |
News Archive
Researchers at the University of Essex, England are embarking on the first phase of a unique project to find out if mobile phone masts, have an adverse effect on our health.
Ajinomoto AminoScience, LLC announced today the launch of AjiPhase™, an evolution of liquid phase peptide synthesis containing the benefits of solid and liquid phase methodologies. This new service is designed as an innovative tool that will enable pharmaceutical companies to expand their development pipeline and provide a uniform production process through the entire development lifecycle.
The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body's internal organs. The AMA's proposals are part of a submission calling for $63 million to fight obesity.
A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.
Chelsea Therapeutics International, Ltd. has completed its previously announced public offering of common stock and announced that the underwriters exercised their option to purchase approximately 1.07 million additional shares to cover over-allotments.
› Verified 7 days ago
| Entity Name | Banner Primary Care Physicians Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417238908 PECOS PAC ID: 6406020155 Enrollment ID: O20111115000898 |
News Archive
Researchers at the University of Essex, England are embarking on the first phase of a unique project to find out if mobile phone masts, have an adverse effect on our health.
Ajinomoto AminoScience, LLC announced today the launch of AjiPhase™, an evolution of liquid phase peptide synthesis containing the benefits of solid and liquid phase methodologies. This new service is designed as an innovative tool that will enable pharmaceutical companies to expand their development pipeline and provide a uniform production process through the entire development lifecycle.
The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body's internal organs. The AMA's proposals are part of a submission calling for $63 million to fight obesity.
A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.
Chelsea Therapeutics International, Ltd. has completed its previously announced public offering of common stock and announced that the underwriters exercised their option to purchase approximately 1.07 million additional shares to cover over-allotments.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Louise Willis, MD 1300 N 12th St, Suite 605, Phoenix, AZ 85006-2848 Ph: (602) 239-2668 | Jennifer Louise Willis, MD 1300 N 12th St, Suite 605, Phoenix, AZ 85006-2848 Ph: (602) 239-4567 |
News Archive
Researchers at the University of Essex, England are embarking on the first phase of a unique project to find out if mobile phone masts, have an adverse effect on our health.
Ajinomoto AminoScience, LLC announced today the launch of AjiPhase™, an evolution of liquid phase peptide synthesis containing the benefits of solid and liquid phase methodologies. This new service is designed as an innovative tool that will enable pharmaceutical companies to expand their development pipeline and provide a uniform production process through the entire development lifecycle.
The Australian Medical Association has recommended the use of graphic television advertisements in Victoria to warn people about the risks of eating fatty foods. Rising rates of obesity has prompted these extreme measures. The proposed ads in television and newspaper would cost $25 million and would show the effects of fat on the body's internal organs. The AMA's proposals are part of a submission calling for $63 million to fight obesity.
A tailored virus destroys brain tumor stem cells that resist other therapies and cause lethal re-growth of cancer after surgery, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in the Sept. 18 edition of the Journal of the National Cancer Institute.
Chelsea Therapeutics International, Ltd. has completed its previously announced public offering of common stock and announced that the underwriters exercised their option to purchase approximately 1.07 million additional shares to cover over-allotments.
› Verified 7 days ago
Dr. Serena Dawn Woods-grimm, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 201 N Central Ave, Phoenix, AZ 85004 Phone: 602-221-6326 | |
Michael Devin Taylor, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree - Family Medicine #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-4122 | |
Dr. Umar Iqbal, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2927 N 7th Ave, Peppertree Building - Window #3, Phoenix, AZ 85013 Phone: 602-406-3153 Fax: 602-406-7176 | |
Jessica Ann Wright, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-1000 | |
Meggan E Bauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4250 E Camelback Rd Ste K100, Phoenix, AZ 85018 Phone: 602-224-9218 | |
Dr. James W. Fisher, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12450 N 32nd St Ste 3, Phoenix, AZ 85032 Phone: 602-996-0924 Fax: 602-482-2624 | |
Geoffrey Peter Radoff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 West Greenway, Suite 210, Phoenix, AZ 85023 Phone: 602-993-0200 Fax: 602-993-0207 |